Eye Injections to Treat Wet Age-Related Macular Degeneration The most common treatments for wet age-related macular degeneration (wet AMD) are designed to counter the proteins which contribute to the development of AMD Your doctor gives you this therapy
Injections for Macular Degeneration: Benefits, Risks, Results Macular degeneration, or age-related macular degeneration (AMD), is a leading cause of vision loss among older adults There are two types of macular degeneration: dry AMD and wet AMD
New Treatments for Age-Related Macular Degeneration For more than a decade, ophthalmologists have treated wet age-related macular degeneration (AMD) with periodic eye injections and dry AMD with antioxidant vitamins These treatments were groundbreaking, offering hope for the first time that this sight-threatening disease could be slowed, and in some cases stopped or even reversed
Eye Injections for Macular Degeneration (AMD) Treatment Receiving eye injections for age-related macular degeneration (AMD) can be a real sight-saver for those with this condition These intravitreal (in-the-eye) injections allow an ophthalmologist to place the medication directly into the vitreous cavity at the back of the eye, where it is needed
Eylea Injection Treatment for Wet Macular Degeneration Regeneron Pharmaceuticals announced that the FDA has approved its Eylea injection treatment for wet age-related macular degeneration (AMD) The treatment, known in the scientific literature as VEGF Trap-Eye, was approved at a recommended dose of 2 mg every four weeks for the first twelve weeks, followed by 2 mg dose every two months (1 2)